Subcutaneous omalizumab + steroid vs placebo + steroid (steroid reduction)
Number of participants achieving complete inhaled steroid withdrawal 28 to 32 weeks · people with asthma
Subcutaneous omalizumab + steroid may leads to higher number of participants achieving complete inhaled steroid withdrawal… compared with placebo + steroid (steroid reduction) (low certainty).
1 finding from 1 review
- OR 2.5 [2, 3.13]4 studies · 1634 participantsLow